Gerald Phd McMahon's Net Worth

$26.7 Million

Estimate Recalculated Sep 8, 2024 07:19PM EST

Who is Gerald Phd McMahon?

Gerald Phd McMahon has an estimated net worth of $26.7 Million. This is based on reported shares across multiple companies, which include Celldex Therapeutics, Inc., NEORX CORP, Harpoon Therapeutics, Inc., and OXIGENE INC.

SEC CIK

Gerald Phd McMahon's CIK is 0001290747

Past Insider Trading and Trends

2008 was Gerald Phd McMahon's most active year for acquiring shares with 8 total transactions. Gerald Phd McMahon's most active month to acquire stocks was the month of May. 2018 was Gerald Phd McMahon's most active year for disposing of shares, totalling 12 transactions. Gerald Phd McMahon's most active month to dispose stocks was the month of May. 2006 saw Gerald Phd McMahon paying a total of $4,177,500.00 for 3,750,000 shares, this is the most they've acquired in one year. In 2017 Gerald Phd McMahon cashed out on 60,120 shares for a total of $192,809.27, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Celldex Therapeutics, Inc. (CLDX) Snapshot price: $44

Investor

Gerald Phd McMahon owns 232,953 units of Common Stock, par value $.001 per share which is worth $10,249,932.00, 192,110 units of Common Stock, par value $0.001 per share which is worth $8,452,840.00 and 180,697 units of Common Stock, par value $0.001 which is worth $7,950,668.00. In the year 2016 Gerald Phd McMahon filed a total of 26 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-1.54%
-2.82K
$0.30
-$843.25
180.7K
Dec 3
Form 4
-1.55%
-2.89K
$0.31
-$908.28
183.52K
Nov 1
Form 4
-1.53%
-2.89K
$0.45
-$1,302.49
186.41K
Oct 1
Form 4
-1.46%
-2.81K
$0.50
-$1,412.13
189.3K
Sep 4
Form 4
-1.44%
-2.81K
$0.47
-$1,308.04
192.11K
Aug 1
Form 4
-1.42%
-2.81K
$0.50
-$1,416.63
194.92K
Jul 2
Form 4
—
0
—
—
0
Jun 13
Form 4
-1.40%
-2.81K
$0.58
-$1,632.10
197.74K
Jun 1
Form 4
-1.38%
-2.81K
$0.74
-$2,081.62
200.55K
May 1
Form 4
-1.63%
-3.38K
$2.33
-$7,873.07
203.36K
Apr 2
Form 4
-1.62%
-3.42K
$2.25
-$7,683.75
206.74K
Mar 1
Form 4
-1.60%
-3.42K
$2.76
-$9,425.40
210.16K
Feb 1
Form 4
-1.69%
-3.67K
$2.84
-$10,408.60
213.57K
Jan 2
Form 4
-1.46%
-3.21K
$3.00
-$9,636.00
217.24K
Dec 1
Form 4
-1.44%
-3.21K
$2.44
-$7,837.28
220.45K
Nov 1
Form 4
-1.42%
-3.21K
$2.86
-$9,186.32
223.66K
Oct 2
Form 4
-1.40%
-3.21K
$2.46
-$7,901.52
226.87K
Sep 1
Form 4
-1.23%
-2.87K
$2.29
-$6,570.01
230.08K
Aug 1
Form 4
-1.22%
-2.87K
$2.47
-$7,086.43
232.95K
Jul 3
Form 4
+4.43%
10K
—
—
235.82K
Jun 15
Form 4
-1.25%
-2.87K
$2.83
-$8,119.27
225.82K
Jun 1
Form 4
-1.24%
-2.87K
$3.33
-$9,553.77
228.69K
May 1
Form 4
-1.22%
-2.87K
$3.61
-$10,357.09
231.56K
Apr 3
Form 4
-12.32%
-32.93K
$3.54
-$116,561.58
234.43K
Mar 1
Form 4
—
0
—
—
0
Dec 14
Form 3
—
0
—
—
0
No matching records found

NEORX CORP No price found

Chief Executive Officer

Gerald Phd McMahon owns 5,000 units of NeoRx Corporation Common Stock, 19,608 units of Common Stock and 73,826 units of Common Stock (PARD). In the year 2004 Gerald Phd McMahon filed a total of 17 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+276.51%
54.22K
—
—
73.83K
Jun 9
Form 4
—
0
—
—
0
Jun 9
Form 4
+61.94%
7.5K
$1.29
$9,707.00
19.61K
Dec 30
Form 4
+155.82%
7.38K
$1.40
$10,325.00
12.11K
Dec 29
Form 4
—
0
—
—
0
Dec 18
Form 4
+468.19%
3.9K
$3.93
$15,327.00
4.73K
Mar 6
Form 4
—
0
—
—
0
Jan 3
Form 4
—
0
—
—
0
Jun 14
Form 4/A
—
0
—
—
0
Jun 16
Form 4/A
—
0
—
—
0
Apr 29
Form 4
—
0
—
—
0
Jun 16
Form 4
—
0
—
—
0
Jun 16
Form 4
—
0
—
—
0
Apr 29
Form 4
—
0
—
—
0
Jan 24
Form 4
∞
5K
$2.75
$13,750.00
5K
May 25
Form 4
—
0
—
—
0
May 18
Form 3
—
0
—
—
0
No matching records found

Harpoon Therapeutics, Inc. (HARP) No price found

President and CEO

Gerald Phd McMahon owns 172,462 units of Common Stock. In the year 2019 Gerald Phd McMahon filed a total of 7 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 28
Form 4
—
0
—
—
0
Jan 31
Form 4
+5,648.73%
169.46K
$0.60
$101,677.20
172.46K
Jun 5
Form 4
+50.00%
1K
$10.16
$10,157.30
3K
May 14
Form 4
+100.00%
1K
$10.56
$10,558.70
2K
May 8
Form 4
∞
1K
$10.53
$10,530.00
1K
May 3
Form 3
—
0
—
—
0
No matching records found

OXIGENE INC (OTLC) Snapshot price: $0.02296

Investor

Gerald Phd McMahon owns 18,611 units of Common Stock, $0.01 par value per share which is worth $427.31. In the year 2011 Gerald Phd McMahon filed a total of 11 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 1
Form 4
—
0
—
—
0
May 28
Form 4
+26.06%
3.85K
—
—
18.61K
Jul 2
Form 4
+32.06%
3.58K
—
—
14.76K
Jan 2
Form 4
+196.32%
7.41K
—
—
11.18K
Jul 1
Form 4
∞
3.77K
—
—
3.77K
Jan 2
Form 4/A
—
0
—
—
0
Jul 1
Form 4
—
0
—
—
0
Jul 2
Form 4
—
0
—
—
0
Jan 2
Form 4
—
0
—
—
0
Sep 20
Form 3
—
0
—
—
0
No matching records found